Delisting riskPopularity #5,120
IRIX · NASDAQ · Medical - Devices

Iridex (IRIX)

Laser systems and procedure probes for glaucoma and retinal care.

$0.6355
After hours+0.00 (+0.39%)
At close$0.6330(−1.56%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Jan 2026Q1 FY26Apr 2026Q2 FY26Jul 2026
Revenue131212131213121412151213
Cost of revenue787777798978
Gross profit654546554654
788866565655
Research & development222211111111
666655454544
Selling & marketing444333233333
General & administrative222322222222
Other expenses000000000000
Operating income−2−3−3−3−2−10−1−100−1
000000−100000
Other non-operating income000000100000
Income before tax−2−3−3−3−2−1−2−1−200−1
Income tax expense000000000000
Net income from continuing operations−2−3−3−3−2−1−2−1−20−1−1
Net income−2−3−3−3−2−1−2−1−20−1−1
EPS, basic−$0.11−$0.18−$0.21−$0.16−$0.12−$0.05−$0.10−$0.06−$0.09−$0.01−$0.03−$0.07
EPS, diluted−$0.11−$0.18−$0.21−$0.16−$0.12−$0.05−$0.10−$0.06−$0.09−$0.01−$0.03−$0.07
Weighted average shares, basic161616161717171717171717
Weighted average shares, diluted161616161717171717171717
EBITDA−1−2−3−2−20−1−1−100−1
Depreciation & amortization010000000000
EBIT−2−3−3−3−2−1−2−1−200−1